Remdesivir and COVID-19: What are the implications for Africa?

Green, R J; Mustafa, F; Sewlall, N; Richards, G A

Green, R J; Mustafa, F; Sewlall, N; Richards, G A.

Green RJ; Steve Biko Hospital and Department of Paediatrics and Child Health, School of Medicine, Faculty of Health Sciences, University of Pretoria, South Africa. robin.green@up.ac.za.

S Afr Med J ; 110(6): 12942, 2020 05 07.

Article in English | MEDLINE | ID: covidwho-743527

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Adenosine Monophosphate/analogs & derivatives; Africa; Alanine/analogs & derivatives; Betacoronavirus; COVID-19; Coronavirus Infections/drug therapy; Double-Blind Method; Humans; SARS-CoV-2; COVID-19 Drug Treatment

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics Type of study: Randomized controlled trials Limits: Humans Country/Region as subject: Africa Language: English Journal: S Afr Med J Year: 2020 Document Type: Article Affiliation country: South Africa

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links